Laboratory Testing Services Market Report 2026

The laboratory testing services market size has grown steadily in recent years. It will grow from $112.52 billion in 2025 to $117.88 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing prevalence of chronic and infectious diseases, growing reliance on laboratory diagnostics for clinical decisions, expansion of hospital-based laboratories, rising demand for routine health checkups, established role of labs in drug development.

The laboratory testing services market size is expected to see strong growth in the next few years. It will grow to $148.26 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to growing aging population requiring regular diagnostics, rising adoption of personalized and genetic testing, expansion of clinical trials and drug discovery activities, increasing focus on early disease detection, growth of standalone diagnostic laboratories. Major trends in the forecast period include rising demand for comprehensive diagnostic testing services, increasing outsourcing of laboratory testing by healthcare providers, growing adoption of high-throughput and specialized tests, expansion of preventive and screening-based laboratory services, improved turnaround time through process optimization.

The increasing prevalence of chronic and infectious diseases is anticipated to drive the growth of the laboratory testing services market in the coming years. Chronic disease refers to a health condition that typically persists for three months or longer and may worsen over time. Laboratory testing services help in monitoring various chronic illnesses, evaluating the quality and performance of new products during development, ensuring quality control during manufacturing, calibrating measuring instruments, and analyzing failures to identify causes and prevent future occurrences. For example, in July 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, chronic conditions accounted for an estimated 4.4 million years of healthy life lost among Australians, representing 85% of the country’s total disease burden for that year. Thus, the increasing prevalence of chronic and infectious diseases is fueling the growth of the laboratory testing services market.

Major companies in the laboratory testing services market are focused on providing testing services facilitated by equipment, such as a compact electromagnetic interference (EMI) test receiver, to provide a compact and efficient solution for precise EMI measurements, enhancing product certification and compliance testing in laboratories. A compact EMI test receiver is a lightweight, portable instrument designed to measure electromagnetic interference (EMI) emissions from electronic devices, ensuring compliance with relevant standards by providing essential functionalities. For instance, in March 2023, Rohde & Schwarz, a Germany-based technology company, launched R&S EPL1000, a new EMI test receiver. This receiver is designed for efficient emission measurements up to 30 MHz. This new instrument is compliant with CISPR 16-1-1, making it suitable for certification measurements and reducing uncertainty in pre-compliance tasks. The R&S EPL1000 is particularly suited for conducted voltage and current emission measurements, aligning with ISO, EN, CISPR, and FCC standards.

In July 2024, Quest Diagnostics Inc., a US-based diagnostics company, acquired LifeLabs Inc. from OMERS for an undisclosed amount. With this acquisition, Quest Diagnostics aims to expand its diagnostic services footprint into Canada by combining its advanced lab and testing capabilities with LifeLabs’ strong community presence, thereby improving access to specialized tests, enhancing digital-health pathways, and strengthening patient care in Canadian markets. LifeLabs Inc. is a Canada-based healthcare technology company that specializes in providing community laboratory testing and digital health connectivity systems.

Major companies operating in the laboratory testing services market are Abbott Laboratories, Siemens Medical Solutions USA Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Eurofins Scientific SE, SGS US Testing Co Inc., Sonic Healthcare Limited, Bureau Veritas S.A., Charles River Laboratories International Inc., SYNLAB International GmbH, Intertek Group plc, Covance Inc., ARUP Laboratories Inc., ALS Limited, Cerba HealthCare SAS, OPKO Health Inc., Bio-Reference Laboratories Inc., NeoGenomics Laboratories Inc., Silliker Inc., Mérieux NutriSciences S.A., Microbac Laboratories Inc., US BioTek Laboratories, American Testing Lab Inc., Unilabs Holding A/S, Element Materials Technology Limited.

North America was the largest region in the laboratory testing services market in 2025. Asia-Pacific is expected to be the global laboratory testing services market report fastest-growing region in the forecast period. The regions covered in the laboratory testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laboratory testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately impacted the laboratory testing services market by increasing costs of imported diagnostic reagents, test kits, and laboratory instruments. Test segments such as genetics, immunology, and microbiology are most affected, particularly in North America and Europe due to dependence on global suppliers. Stand-alone and hospital-based laboratories face higher operational and testing costs, which may influence service pricing. However, tariffs have also encouraged regional sourcing of consumables, strengthened domestic diagnostic manufacturing, and supported long-term resilience of laboratory service supply chains.

The laboratory testing services market research report is one of a series of new reports that provides laboratory testing services market statistics, including laboratory testing services industry global market size, regional shares, competitors with a laboratory testing services market share, detailed laboratory testing services market segments, market trends and opportunities, and any further data you may need to thrive in the laboratory testing services industry. This laboratory testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Laboratory testing services involve performing medical procedures or tests in a controlled environment equipped with the necessary tools, materials, and trained personnel.

The main types of tests in laboratory testing services include clinical chemistry, immunology, cytology, genetics, microbiology, hematology, and others. Laboratory testing services are utilized to detect and quantify various chemicals in blood and urine, which are the two clinical chemistry specimens analyzed most frequently. These services serve multiple purposes, including bioanalytical and laboratory chemistry services, toxicology testing, cell and gene therapy-related services, preclinical and clinical trial support, drug discovery and development services, and other offerings provided by stand-alone laboratories, hospital-based laboratories, contract research organizations, and additional providers.

The laboratory testing services market includes revenues earned by entities from pathogen testing services, biological testing services, toxicology laboratory testing services, and N95 mask laboratory testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.